Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 38,900 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of the business’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $55.74, for a total transaction of $2,168,286.00. Following the completion of the transaction, the chief executive officer directly owned 251,983 shares in the company, valued at $14,045,532.42. This trade represents a 13.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, October 12th, John Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00.
• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The stock was sold at an average price of $46.42, for a total transaction of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The shares were sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.

Heartflow Price Performance

Heartflow stock opened at $55.80 on Wednesday. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $60.56. The firm has a 50 day moving average price of $51.56 and a 200-day moving average price of $34.87.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million for the quarter. The firm’s revenue was up 47.7% on a year-over-year basis. On average, research analysts predict that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Institutional Trading of Heartflow

Institutional investors have recently modified their holdings of the business. XXEC Inc. bought a new position in Heartflow in the 2nd quarter worth approximately $2,524,764,000. BlackRock Inc. bought a new stake in Heartflow during the 2nd quarter valued at $152,502,000. Bamco Inc. NY purchased a new stake in shares of Heartflow during the second quarter worth $94,625,000. Jupiter Topco LLC purchased a new stake in shares of Heartflow during the second quarter worth $70,983,000. Finally, Janus Henderson Group PLC boosted its holdings in shares of Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after acquiring an additional 1,315,416 shares during the period.

Analyst Ratings Changes

Several analysts have issued reports on the company. Robert W. Baird set a $45.00 target price on Heartflow in a research note on Friday, August 14th. Wall Street Zen cut Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday. Stifel Nicolaus increased their price target on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Heartflow in a report on Wednesday, November 4th. Finally, UBS Group assumed coverage on Heartflow in a report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $48.62.

About Heartflow

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.